Nivolumab 10 MG/ML Intravenous Solution Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Rectal Cancer Stage IIRectal Cancer Stage III
Jules Bordet Institute72 enrolled10 locationsNCT04503694
Recruiting
Phase 2
Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen90 enrolled4 locationsNCT04205552